Home>Diabetics>Zitaneo GM-IR-50/1000/2
Zitaneo GM-IR-50/1000/2

Zitaneo GM-IR-50/1000/2

Composition: Sitagliptin 50 mg, Metformin Hydrochloride IP 1000 mg, Glimepiride IP 2 mg.
Indicated for the management of type 2 diabetes mellitus by improving insulin sensitivity, enhancing glucose metabolism, and maintaining glycemic control.

Category:

Description

Zitaneo GM-IR-50/1000/2 is a combination oral antidiabetic medication designed to provide comprehensive glycemic control in patients with type 2 diabetes mellitus. It combines three powerful agents:

  • Sitagliptin (50 mg): A DPP-4 inhibitor that enhances incretin hormone activity, promoting insulin secretion and reducing glucagon release.
  • Metformin Hydrochloride (1000 mg): A biguanide that improves insulin sensitivity, reduces hepatic glucose production, and enhances peripheral glucose uptake.
  • Glimepiride (2 mg): A sulfonylurea that stimulates pancreatic beta cells to increase insulin secretion, aiding in better blood sugar regulation.

This triple-drug combination works synergistically to manage postprandial and fasting blood sugar levels effectively. Zitaneo GM-IR-50/1000/2 helps prevent diabetes-related complications by improving insulin function, reducing insulin resistance, and maintaining stable glucose levels.

Related products